Capital Nasdaq (Taiwan) Profile

00678 Etf  TWD 28.91  0.27  0.94%   

Performance

Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Capital Nasdaq is selling for under 28.91 as of the 25th of March 2025; that is 0.94 percent increase since the beginning of the trading day. The etf's last reported lowest price was 28.89. Capital Nasdaq has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 25th of December 2024 and ending today, the 25th of March 2025. Click here to learn more.
CAPITAL SECURITIES is traded on Taiwan Stock Exchange in Taiwan. More on Capital Nasdaq Biotechnology

Moving together with Capital Etf

  0.6700878 Cathay SustainabilityPairCorr

Moving against Capital Etf

  0.6600674R Yuanta SecuritiesPairCorr
  0.4100642U Yuanta SP GSCIPairCorr
  0.3400715L Paradigm SP GSCIPairCorr

Capital Etf Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Capital Nasdaq's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Capital Nasdaq or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business Concentrationnull, Capital Investment Trust Co., Ltd (View all Sectors)
Beta In Three Year1.02
As Of Date31st of March 2021
Capital Nasdaq Biotechnology [00678] is traded in Taiwan and was established 2017-01-09. The fund is listed under null category and is part of Capital Investment Trust Co., Ltd family. Capital Nasdaq Biote presently have 178.4 M in total net assets. , while the total return for the last 3 years was 8.82%.
Check Capital Nasdaq Probability Of Bankruptcy

Capital Nasdaq Biote Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Capital Nasdaq. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

Capital Nasdaq Biote Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Capital Nasdaq Biote Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Capital Nasdaq price patterns.

Capital Nasdaq Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Capital Nasdaq without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Earnings Calls Now

   

Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module

Other Information on Investing in Capital Etf

Capital Nasdaq financial ratios help investors to determine whether Capital Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Capital with respect to the benefits of owning Capital Nasdaq security.